Pfizer and BioNTech begin a study of an Omicron vaccine, with initial results expected in the first half of the year. A+ A- Print Email By BY BENJAMIN MUELLER from NYT Health https://ift.tt/3tZVqr6
Post a Comment Blogger Facebook
Thanks for commenting. I hope you will do again.